Chinese buyers struggle through Cfius quagmire

Donald Trump's delay in appointing key officials is already slowing down the approval process for M&A deals in the US – even before any policy changes kick in.

Excitement and suprise greeted a decision by a key US regulatory panel to approve ChemChina's record $43 billion acquisition of Syngenta last August.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media